The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Paylocity Holding Corp
F:0P7
|
US |
|
Clinuvel Pharmaceuticals Ltd
ASX:CUV
|
AU |
|
Cemindo Gemilang Tbk PT
IDX:CMNT
|
ID |
|
Kri-Kri Milk Industry SA
F:AO2
|
GR |
|
F
|
FMS Enterprises Migun Ltd
OTC:FTCFF
|
IL |
|
Citizen Watch Co Ltd
F:CTZ
|
JP |
|
T
|
Toyobo Co Ltd
F:TO7
|
JP |
|
DBS Group Holdings Ltd
F:DEVL
|
SG |
|
Marui Group Co Ltd
F:MUI
|
JP |
|
I
|
Imperial Pacific Ltd
ASX:IPC
|
AU |
|
Chemed Corp
F:CXM
|
US |
|
Domino's Pizza Enterprises Ltd
ASX:DMP
|
AU |
|
Revive Therapeutics Ltd
F:31R
|
CA |
|
M
|
Matsui Securities Co Ltd
XMUN:MTW
|
JP |
|
C
|
Citizen Watch Co Ltd
OTC:CHCLY
|
JP |
|
T
|
Toyota Tsusho Corp
F:9TO
|
JP |
|
Telefonaktiebolaget LM Ericsson
F:ERCA
|
SE |
|
Kubota Corp
TSE:6326
|
JP |
|
Nusa Palapa Gemilang Tbk PT
IDX:NPGF
|
ID |
|
S
|
Sociedad Quimica y Minera de Chile SA
F:QYM
|
CL |
Paylocity Holding Corp (0P7)’s 12-month stock price forecast through October 2027 has a consensus target of €153.44, implying 4% upside. The forecast is based on price targets from 24 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
0P7 is 153.44 EUR with a low forecast of 107.25 EUR and a high forecast of 232.29 EUR.
Over the last 14 years, the compound annual growth rate for Revenue has been 28%. The projected CAGR for the next 4 years is 9%.
Over the last 14 years, the compound annual growth rate for Gross Profit has been 32%. The projected CAGR for the next 4 years is 9%.
Over the last 14 years, the compound annual growth rate for Operating Income has been 42%. The projected CAGR for the next 3 years is 26%.
Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 43%. The projected CAGR for the next 3 years is 25%.
Over the last 14 years, the compound annual growth rate for Net Income has been 49%. The projected CAGR for the next 3 years is 31%.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
AI-generated answers can contain mistakes, outdated facts, or incomplete information. Always verify important details before making decisions.
The AI Assistant is designed for research and education. It does not provide personalized investment, legal, or tax advice.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more